1
0
0
(1 - 15 von 16
)
patentbuddy: Roland WESCH
SANOFI-AVENTIS DEUTSCHLAND GMBH, Frankfurt am Main, DE
Drug Discovery and Evaluation: Safety and Pharmacokinetic ...books.google.com › books
books.google.com
... Roland Wesch Aventis Pharma Deutschland GmbH A company of the Sanofi-Aventis Group DI& A DMPK Industriepark Hoechst, Building G Frankfurt Germany ...
Drug Discovery and Evaluation: Safety and Pharmacokinetic ...google.pl
books.google.pl
... Building H Frankfurt Germany Dr. Roland Wesch Aventis Pharma Deutschland GmbH A company of the Sanofi-Aventis Group DI& A DMPK Industriepark ...
Effect of a single dose of insulin glargine/lixisenatide fixed ratio ...dom-pubs.onlinelibrary.wiley.com
dom-pubs.onlinelibrary.wiley.com
· ... Roland Wesch PhD,. Roland Wesch PhD. Research & Development, Sanofi-Aventis Deutschland GmbH, Frankfurt, Germany. Search for more papers by ...
Drug Discovery And Evaluation: Methods In Clinical Pharmacology ...vdoc.pub
vdoc.pub
Roland Wesch R&D Metabolism and PK Germany Sanofi-Aventis Deutschland GmbH Industriepark Hoechst Building H Frankfurt am Main Germany Roland.Wesch ...
Drug Discovery and Evaluation - Safety and Pharmacokinetic Assays ...www.scribd.com
www.scribd.com
Roland Wesch Sanofi Deutschland GmbH, Frankfurt am Main, Germany Hongbo Zhai Department of Dermatology, UC San Francisco, San Francisco, CA, USA Manfred ...
[PDF] nr Patentstyretsearch.patentstyret.no
search.patentstyret.no
Roland Wesch, c/o Sanofi-Aventis Deutschland GmbH, FRANKFURT AM MAIN, Tyskland (DE). Heiko Meier, c/o Sanofi-Aventis Deutschland GmbH, FRANKFURT ...
Patents Assigned to SanofiJustia
patents.justia.com
Publication date: November 13, Applicant: sanofi-aventis Deutschland GmbH. Inventors: Caren SOENNICHSEN, Roland WESCH, Heiko MEIER ...
Specific Studies for Formulation DevelopmentSpringer
link.springer.com
von R Wesch · — Roland Wesch. Contents. Purpose and Rationale Deutschland GmbH, Frankfurt am Main, Germany ; Roland.
Drug Discovery and Evaluation: Methods in Clinical Pharmacology ...dokumen.pub
dokumen.pub
... Roland Wesch R&D Metabolism and PK Germany, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany Lea Wettlaufer Medisis, Neustadt, Germany Beat ...
[PDF] Drug Discovery and Evaluationndl.ethernet.edu.et
ndl.ethernet.edu.et
... Roland Wesch. Aventis Pharma Deutschland GmbH. A company of the Sanofi-Aventis Group. DI& A DMPK. Industriepark Hoechst, Building G Frankfurt.
[PDF] Norsk Patenttidende nr Patentstyretsearch.patentstyret.no
search.patentstyret.no
Roland Wesch, c/o Sanofi-Aventis Deutschland GmbH,. FRANKFURT AM MAINDE. Heiko Meier, c/o Sanofi-Aventis Deutschland GmbH,. FRANKFURT AM MAIN,
单剂量胰岛素甘精胰岛素/利西塞那肽固定比例组合(iGlarLixi)对日本2 ...www.x-mol.com
www.x-mol.com
... Roland Wesch 2 , Yasuhiro Hashimoto 3. Affiliation. SOUSEIKAI PS Clinic, Fukuoka, Japan. Research & Development, Sanofi-Aventis Deutschland GmbH, Frankfurt ...
(21) (13) L (12) UTDRAG (19) NO (51) Int Cl NORGE ...mickhai-marko.narod.ru › nord › 2.htm
mickhai-marko.narod.ru
... Sanofi-Aventis Deutschland GmbH, FRANKFURT AM MAIN, DE Roland Wesch, c/o Sanofi-Aventis Deutschland GmbH, FRANKFURT AM MAIN, ...
nr 20/ NO årgang 98 ISSN - PDF Gratis nedlasting
docplayer.me
... DE Caren Soennichsen, c/o Sanofi-Aventis Deutschland GmbH, FRANKFURT AM MAINDE Roland Wesch, c/o Sanofi-Aventis Deutschland GmbH, ...
Alle Infos zum Namen "Roland Wesch"
sortiert nach Relevanz / Datum